Literature DB >> 15717289

Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome?

P G Lindqvist1, J Molin.   

Abstract

OBJECTIVES: Most obstetric clinics have a program for the identification of small-for-gestational age (SGA) fetuses because of the increased risk of fetal complications that they present. We have a structured model for the identification and follow-up of SGA pregnancies. We aimed to determine whether the recognition of SGA antepartum improves fetal outcome.
METHODS: All pregnancies at Malmö University Hospital from 1990 to 1998 (n = 26 968) were reviewed. SGA fetuses identified prior to delivery (n = 681) were compared with those not identified (n = 573). Also, all pregnancies with SGA fetuses were compared with those appropriate-for-gestational age (AGA) (n = 24 585). The risk of serious fetal complications (hypoxic encephalopathy grade 2 or 3, intracranial hemorrhage, Apgar score <4 at 5 min, neonatal convulsions, umbilical pH <7.0, cerebral palsy, mental retardation, stillbirth, intrapartum or infant death) was assessed with cross-tabulation and logistic regression analysis, adjusted for gestational age and degree of SGA.
RESULTS: When compared with SGA fetuses identified before delivery (54%), SGA fetuses not identified before delivery were characterized by a four-fold increased risk of adverse fetal outcome (odds ratio, 4.1; 95% CI, 2.5-6.8). Similarly, compared with AGA fetuses, SGA fetuses were associated with a four-fold increased risk of serious fetal complications.
CONCLUSIONS: A structured antenatal surveillance program for fetuses identified as SGA results in a lower risk of adverse fetal outcome, compared with cases of SGA fetuses not identified antepartum.

Entities:  

Mesh:

Year:  2005        PMID: 15717289     DOI: 10.1002/uog.1806

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  66 in total

1.  Customised birthweight standards accurately predict perinatal morbidity.

Authors:  Francesc Figueras; Josep Figueras; Eva Meler; Elisenda Eixarch; Oriol Coll; Eduard Gratacos; Jason Gardosi; Xavier Carbonell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-24       Impact factor: 5.747

2.  In vivo placental MRI shape and textural features predict fetal growth restriction and postnatal outcome.

Authors:  Sonia Dahdouh; Nickie Andescavage; Sayali Yewale; Alexa Yarish; Diane Lanham; Dorothy Bulas; Adre J du Plessis; Catherine Limperopoulos
Journal:  J Magn Reson Imaging       Date:  2017-07-22       Impact factor: 4.813

3.  Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?

Authors:  Manouk L E Hendrix; Judith A P Bons; Roy R G Snellings; Otto Bekers; Sander M J van Kuijk; Marc E A Spaanderman; Salwan Al-Nasiry
Journal:  Fetal Diagn Ther       Date:  2019-05-08       Impact factor: 2.587

Review 4.  Fetal cardiovascular magnetic resonance imaging.

Authors:  Julien Aguet; Mike Seed; Davide Marini
Journal:  Pediatr Radiol       Date:  2020-11-30

5.  The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Madhulika B Gupta
Journal:  J Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.782

6.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 7.  Routine ultrasound in late pregnancy (after 24 weeks' gestation).

Authors:  Leanne Bricker; Nancy Medley; Jeremy J Pratt
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

8.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

9.  Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies.

Authors:  Suneet P Chauhan; Madeline Murguia Rice; William A Grobman; Jennifer Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Kenneth J Leveno; Steve N Caritis; Mona Prasad; Alan T N Tita; George Saade; Yoram Sorokin; Dwight J Rouse; Jorge E Tolosa
Journal:  Obstet Gynecol       Date:  2017-09       Impact factor: 7.661

10.  Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.

Authors:  M López; M Palacio; A Goncé; S Hernàndez; F J Barranco; L García; M Loncà; J O Coll; E Gratacós; F Figueras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.